Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
7
×
national blog main
boston top stories
clinical trials
fda
san francisco blog main
boston
san diego blog main
investing
ipo
national top stories
new york blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
dyne therapeutics
gene therapy
indiana blog main
indiana top stories
loxo oncology
medical device
messenger rna
myotonic dystrophy type 1
national
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
What
ipo
7
×
therapeutics
7
×
drug
medicines
million
new
developing
raised
biotech
biotechs
cancer
companies
company
dyne
genetic
muscle
public
rare
treat
affects
ago
allogene
americans
approved
bio
black
brings
clinic
club
considering
continued
crispr
crop
data
date
debut
diamond
diseases
disorders
diversity
Language
unset
Current search:
therapeutics
×
ipo
×
" life sciences "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M